
Abstract Introduction/Objective Phototherapy reduces severe complications in newborns with unconjugated hyperbilirubinemia, changes hematological values and converts bilirubin into water-soluble forms. However, little published data is available in resource-limited settings such as Ethiopia. This study was aimed to assess the effect of phototherapy on the hematological values and bilirubin levels of newborns with unconjugated hyperbilirubinemia at Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Methods/Case Report A cross-sectional study was conducted among 195 newborns exhibiting unconjugated hyperbilirubinemia from February to April 2024. A convenient sampling technique was used. The data was analyzed with SPSS version 25 using a paired t-test, and a p-value of less than 0.05 was considered statistically significant. Results Red blood cell counts, hemoglobin, hematocrit, mean cell hemoglobin concentration, red cell distribution width, platelet count and monocyte percentage were significantly decreased at 24 and 48 hours (p < 0.01) but not at 72 hours. WBC and lymphocyte percentages were increased at 24 and 48 hours but not at 72 hours. Moreover, bilirubin level significantly decreased (p < 0.001). Conclusion Phototherapy significantly changed the hematological profile and bilirubin levels. Monitoring of hematological parameters is critical during phototherapy.
Abstract Introduction/Objective Well-differentiated neuroendocrine tumors (WD-NETs) of the bladder are exceedingly rare, with fewer than 30 reported cases. SATB2 is a highly sensitive and specific marker for lower gastrointestinal (GI) tract NETs, particularly rectal and appendiceal origin. We present the first reported case of a SATB2-positive WD-NET involving the lower urinary tract of bladder, challenging primary origin and suggesting metastatic lower GI disease. Methods/Case Report A 71-year-old male presented with urinary urgency and frequency. Cystoscopy revealed a small lesion on the bladder-facing aspect of the prostate. Transurethral resection of the prostate (TURP) demonstrated a WD-NET (Ki-67 3–4%, 2 mitoses/10 HPF) positive for synaptophysin, chromogranin, CAM5.2, and SATB2, but negative for prostatic (NKX3.1) and urothelial (p63, GATA3) markers. Clinical history included prior small bowel obstruction and newly identified multifocal lytic bone lesions; myeloma and prostate carcinoma were excluded. Results NA Conclusion SATB2 positivity, in the absence of prostatic and urothelial markers, strongly supports metastatic WD-NET of lower gastrointestinal origin rather than a primary urogenital neoplasm. To our knowledge, this represents the first reported case of metastatic WD-NET involving the bladder, underscoring the critical role of immunohistochemistry and clinicopathologic correlation in accurately determining tumor origin and informing diagnosis, staging, and management of neuroendocrine tumors at unusual sites.
Abstract Introduction/Objective Differentiating chronic myeloid leukemia (CML) from reactive leukocytosis and morphologic mimics, including chronic myelomonocytic leukemia (CMML), chronic neutrophilic leukemia, atypical CML, and other myeloproliferative neoplasms, remains challenging during initial peripheral blood review. We retrospectively evaluated myeloid clustering as a potential morphologic marker for identifying BCR-ABL1–positive clones. Methods/Case Report Peripheral blood smears from 28 cases, including 10 BCR-ABL1–positive CML cases and 18 controls with reactive leukocytosis, CMML, and JAK2-positive neoplasms, were reviewed. Myeloid clustering was defined as groups of more than two immature myeloid precursors with touching cytoplasmic borders. Five monolayer fields per case were reviewed at 40x, with 100x oil immersion used for confirmation when needed. Results A threshold of more than three clusters showed 100% sensitivity and 89% specificity for CML (specificity = 16/18 controls negative). Clustering was absent in reactive mimics, including cases with white blood cell(WBC) counts up to 51.6 × 10^9/L, and was only occasional in CMML, where it lacked the density and distribution seen in CML. Clustering persisted in CML cases with lower WBC, making this useful diagnostic tool. Conclusion Myeloid clustering is a specific, reproducible finding guiding triage for BCR-ABL1 for early CML detection during routine smear evaluation.
Abstract Introduction/Objective Acute myeloid leukemia (AML) with myelodysplasia-related features represents a high-risk subtype often associated with prior myelodysplastic syndromes; however, it may present without documented history. This case highlights the role of morphology in identifying secondary AML. Methods/Case Report A patient presented with left leg swelling, bone pain, bruising, and epigastric discomfort. Laboratory evaluation showed anemia (hemoglobin 9.7 g/dL), leukopenia (3.5 × 10⁹/L), and normal platelet count. Peripheral smear revealed anisopoikilocytosis, dysplastic neutrophils, variable platelets, and ∼25% blasts. Bone marrow aspirate was suboptimal; trephine biopsy demonstrated hypercellular marrow with increased blasts, Auer rods, reduced erythropoiesis, and marked multilineage dysplasia, particularly abnormal megakaryocytes with multinuclearity and nuclear irregularities. Immunohistochemistry showed MPO and CD117 positivity, with negative lymphoid markers (TdT, CD3, CD79a, PAX5) and CD34 negativity. Results NA Conclusion This case demonstrates AML with myelodysplasia-related features presenting without prior history of myelodysplastic syndrome. Prominent multilineage dysplasia supports a secondary origin. Recognition of this entity is critical due to its adverse prognosis. Integration of morphology, immunophenotyping, and molecular studies is essential for accurate diagnosis and risk stratification.
Abstract Introduction/Objective Salivary gland neoplasms are a heterogeneous group with overlapping morphologic features that can present diagnostic challenges. Striated duct adenoma (SDA) is a rare, recently recognized benign to low-grade tumor characterized by compact tubules with variable cystic change, composed of a monophasic population of eosinophilic columnar to cuboidal cells with uniform nuclei and scant stroma. Despite these features, SDA remains underrecognized and may mimic other low-grade salivary neoplasms, particularly in cases with atypical architecture. Methods/Case Report A 46-year-old man presented with a 1.5-year history of a slowly enlarging left parotid mass associated with intermittent discomfort. Imaging demonstrated an enhancing lesion measuring up to 2.7 cm. Fine needle aspiration suggested a low-grade salivary neoplasm, and the patient underwent parotidectomy. Histologic examination revealed a multinodular epithelial neoplasm with fibrosis and no high-grade features. Tumor cells were diffusely positive for S100 and SOX10, with low Ki-67 and no myoepithelial marker expression. Molecular testing identified an IDH2 p.R172T mutation. Results NA Conclusion SDA demonstrates a broader morphologic spectrum, including multinodular and fibrotic patterns that may mimic malignancy. Recognition of its characteristic immunoprofile and IDH2 mutation is critical to avoid misdiagnosis and overtreatment.